The Board of Beijing Tong Ren Tang Chinese Medicine Company Limited announced that, on 13 May 2020, the Company and Tong Ren Tang Technologies entered into the TRT Tech PRC Distribution Framework Agreement, pursuant to which, Tong Ren Tang Technologies Group, as a non-exclusive distributor of the Group, would purchase the Relevant Products from the Group and then sell the same to, among others, distributors, retailers or end users in the PRC or for the purpose of production for a period from 13 May 2020 to 31 December 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.28 HKD | +0.22% | +2.77% | -23.56% |
Mar. 29 | Beijing Tong Ren Tang Chinese Medicine CEO Steps Down; Acting CEO Appointed | MT |
Mar. 28 | Beijing Tong Ren Tang Chinese Medicine Company Limited Announces CEO Changes | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.56% | 990M | |
+24.17% | 562B | |
-6.23% | 358B | |
+20.04% | 322B | |
+8.01% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.51% | 149B | |
-6.37% | 146B |
- Stock Market
- Equities
- 3613 Stock
- News Beijing Tong Ren Tang Chinese Medicine Company Limited
- Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Announce the TRT Tech PRC Distribution Framework Agreement